Visualitza per autor "PASSARO, ANTONIO"
Ara mostrant els elements 1-2 d 2
-
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Wang, Jie F.; Wang, Yan; Lee, Se-hoon; Melosky, Barbara; SHIH, JIN-YUAN; PASSARO, ANTONIO; FELIP, ENRIQUETA (Elsevier, 2024-01) -
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
PASSARO, ANTONIO; Addeo, Alfredo; von Garnier, Christophe; Blackhall, Fiona; PLANCHARD, DAVID; FELIP, ENRIQUETA (BMJ, 2020-06-23)